Clinical Trial of Pregabalin and COX2 in Spinal Stenosis

• Status: Unknown status
• Trial end date: 2019-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Aim of this prospective, single-blind, randomized study was to compare the efficacy of the combination of celecoxib and pregabalin and celecoxib only monotherapy for treatment of chronic low-back pain.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Bundang Hospital
• Treatments: Celecoxib; Cyclooxygenase 2 Inhibitors; Pregabalin

Criteria

Inclusion Criteria:

• Spinal stenosis

Exclusion Criteria:

• Koval grade >=3

• Other musculoskeletal disorders which cause pain on other joint

• Bleeding risk or ulcer history

• Severe cardiovascular, pulmonary, renal, brain, liver dysfunction